Countries covered: Global
Dermatologic diseases affect an estimated 50 million Americans and result in over $2 billion in annual sales of prescription medications with an estimated yearly growth rate of 5% .
Theta’s report is designed to present the most up-to-date information and projections about dermatologic and skin disease therapeutics markets. In order to help your organization make educated decisions in this market, Theta’s study focuses on a market analysis by drug class, geographic region, competitive positions of major players, and competitive dynamics affecting market change. The report includes a thorough analysis of treatment advances and probable future offerings in this market.
The disease areas covered in this study include:
- Psoriasis
- Scleroderma
- Eczema/Atopic Dermatitis
- Acne
- Skin Cancer/Melanoma
Please Note: Theta requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.
Related Reports:
Cancer Melanoma or Skin Cancer Therapy Area Pipeline Report
Dermatology Acne Therapy Area Pipeline Report
Dermatology Alopecia (Hair Loss) Therapy Area Pipeline Report
Dermatology Burns Therapy Area Pipeline Report
Dermatology Psoriasis Therapy Area Pipeline Report
Dermatology Scabies Therapy Area Pipeline Report
Dermatology Seborrheic Dermatitis Therapy Area Pipeline Report
Dermatology Skin Infections or Dermatosis or Skin Itching Therapy Area Pipeline Report
Dermatology Tinea Pedis (Athlete's Foot) Therapy Area Pipeline Report
Dermatology Wounds or Wound Dressing Therapy Area Pipeline Report
|
(0 items)
